Sleep-related disorders, diabetes and obesity: Understanding the facts

Current Respiratory Medicine Reviews

Volumn 2, Issue 3, 2006, Pages 325-329

  Nieto, Javier ^a   Surani, Salim ^b   Huerta Alardín, Ana L ^a   Varon, Joseph ^c,d,e  

^a UNIVERSIDAD AUTÓNOMA DE TAMAULIPAS   (Mexico)

^b TEXAS A AND M UNIVERSITY CORPUS CHRISTI   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e NONE   (United States)

Author keywords

Diabetes mellitus; Insulin resistance; Obesity; Sleep apnea; Sleep related disorders

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LEPTIN;

ANAMNESIS; AROUSAL; AUTONOMIC NEUROPATHY; CLINICAL FEATURE; CORRELATION ANALYSIS; DAYTIME SOMNOLENCE; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FREQUENCY ANALYSIS; GENDER BIAS; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MATURITY ONSET DIABETES MELLITUS; OBESITY; OXYGEN SATURATION; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP DISORDERED BREATHING; THERAPY EFFECT; UPPER AIRWAY RESISTANCE SYNDROME;

EID: 33747631540     PISSN: 1573398X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339806778019006     Document Type: Review

References (65)

1. Punjabi MN, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002; 165: 677-82.
2. Strohl KP, Novak RD, Singer W, Cahn C, Boehm KM, Denko CW, Hoffstem VS. Insulin levels, blood pressure and sleep apnea. Sleep 1994; 17: 614-8.
3. White DP. Pathophysiology of obstructive sleep apnea. Thorax 1995; 50: 797-804.
4. Stoohs RA, Fachini F, Guilleminault C. Insulin resistance and sleep-disordered breathing in healthy humans. Am J Respir Crit Care Med 1996; 154: 170-4.
5. Rosenow F, McCarthy V, Caruso AC. Sleep apnea in endocrine disease. J Sleep Res 1998; 7: 3-11.
6. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt in metabolic and endocrine function. Lancet 1999; 354: 1435-9.
7. Chasens ER, Weaver TE, Umlauf MG. Insulin resistance and obstructive sleep apnea: is increased sympathetic stimulation the link? Biol Res Nurs 2003; 5: 87-96.
8. Bottini P, Dottorini ML, Cordoni MC, Casnecia G, Tantucci C. Sleep disordered breathing in non-obese diabetic subject with autonomic neuropathy. Eur Respir J. 2003; 22: 654-60.
9. Stevenson JE. Diagnosis of sleep apnea. West J Med 2003; 102: 25-7.
10. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-5.
11. Grunstein RR, Stenlof K, Hedner J, Sjostrom L. Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) study. Int J Obes Relat Metab Disord 1995; 19: 410-8.
12. Flemons W, Remmers JE. The diagnosis of sleep apnea: questionnaires and home studies. Sleep 1996; 19: S243-7.
13. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283: 1829-36.
14. Ficker JH, Dertinger SH, Siegfried W, et al. Obstructive sleep apnea and diabetes mellitus: the role of cardiovascular autonomic neuropathy. Eur Respir J 1998; 11: 14-9.
15. Coughlin S, Calverley P, Wilding J. Sleep disordered breathing - a new component of syndrome X? Obes Rev 2001; 2: 267-74.
16. Ferini-Strambi L, Fantini ML, Castronovo C. Epidemiology of obstructive sleep apnea syndrome. Minerva Med 2004; 95: 187-202.
17. Olson LG, King MT, Hensley MJ, Saunders NA. A community study of snoring and sleep-disordered breathing: prevalence. Am J Respir Crit Care Med 1995; 152: 711-6.
18. Cooper BG, White JE, Ashworth LA, Alberti KG, Gibson GJ. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 1995; 18: 172-9.
19. Elmasry A, Lindberg E, Berne C, et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001; 249: 153-61.
20. Harsch IA, Hahn EG, Konturek PC. Insulin resistance and other metabolic aspects of the Obstructive Sleep Apnea Syndrome. Med Sci Monit 2005; 11: RA70-5.
21. Page NM, Watkins PJ. Cardiopulmonary arrest and diabetic autonomic neuropathy. Lancet 1978; 1: 14-6.
22. Resnick HE, Redline S, Shahar E, et al. Sleep Heart Health Study. Diabetes and sleep disturbances: Findings from the Sleep Heart Health Study. Diabetes Care 2003; 26: 702-9.
23. Lamond N, Tiggemann M, Dawson D. Factors predicting sleep disruption in type II diabetes. Sleep 2000; 23: 415-6.
24. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep disordered breathing in women. Am J Respir Crit Care Med 2001; 163: 608-13.
25. Fogel RB, Pillar G, Pittman SD, Dunaif A, White DP. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2001; 86: 1175-80.
26. Saaresranta T, Polo O. Hormones and breathing. Chest 2002; 122: 2165-82.
27. Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients. Effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994; 79: 1681-5.
28. Carlson JT, Hedner JA, Ejnell H, Peterson LE. High prevalence of hypertension in sleep apnea patients independent of obesity. Am J Respir Crit Care Med 1994; 150: 72-7.
29. Neumann C, Martinez D, Schmid H. Nocturnal Oxygen desaturation in diabetic patients with severe autonomic neuropathy. Diabetes Res Clin Pract 1995; 28: 97-102.
30. Strohl KP. Diabetes and sleep apnea. Sleep 1996; 19: S225-8.
31. Grunstein RR. Metabolic aspects of sleep apnea. Sleep 1996; 19: S218-20.
32. Sue DY. Obesity and pulmonary function: more or less? Chest 1997; 111: 844-5.
33. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kates A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998; 157: 144-8.
34. Wilcox I, McNamara SG, Collins FL, Grunstein RR, Sullivan CF. "Syndrome Z": the interaction of sleep apnea, vascular risk factors and heart disease. Thorax 1998; 53: S25-8.
35. Vgontzas AN, Kales A. Sleep and its disorders. Annu Rev Med 1999; 50: 387-400.
36. Shigeta H, Shigeta M, Nakazawa A, Nakamura N, Yoshikawa T. Lifestyle, obesity and insulin resistance. Diabetes Care 2001; 24: 608-09.
37. Manzella D, Parillo M, Razzino T, et al. Soluble leptin receptor and insulin resistance as determinant of sleep apnea. Int J Obes Relat Metab Disord 2002; 26: 370-5.
38. Al-Delaimy WK, Manson JE, Willett WC, Stampfer MJ, Hu FB. Snoring as a risk factor for type 2 diabetes mellitus: a prospective study. Am J Epidemiol 2002; 155: 387-93.
39. Vgontzas AN, Chrousos GP. Sleep-disordered breathing, sleepiness, and insulin resistance: is the latter a consequence, a pathogenetic factor, or both? Sleep Med 2002; 3: 389-91.
40. Schafer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Herthold HK. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 2002; 122: 829-39.
41. Brown LK. A waist is a terrible thing to mind: Central obesity, the metabolic syndrome, and sleep apnea hypopnea syndrome. Chest 2002; 122: 774-8.
42. Vgontzas AN, Bixler EO, Chrousos GP. Metabolic disturbances in obesity versus sleep apnea: the importance of visceral obesity and insulin resistance. J Intern Med 2003; 254: 32-44.
43. Meslier N, Gagnadoux F, Giraud P, et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnea syndrome. Eur Respir J 2003; 22: 156-60.
44. Bottini P, Tantucci C. Sleep apnea syndrome in endocrine diseases. Respiration 2003; 70: 320-7.
45. Tassone F, Lanfranco F, Gianotti L, et al. Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables. Clin Endocrinol 2003; 59: 374-9.
46. Goodfriend TL, Calhoun DA. Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 2004; 43: 518-24.
47. Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela-Bueno A, Kales A. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab 2005; 90: 4510-5.
48. Renko AK, Hiltunen L, Laakso M, Rajala U, Keinanen-Kiukaanniemi S. The relationship of glucose tolerance to sleep disorders and daytime sleepiness. Diabetes Res Clin Pract 2005; 67: 84-91.
49. Teramoto S, Yamamoto H, Yamaguchi Y, Namba R, Ouchi Y. Obstructive sleep apnea causes systemic inflammation and metabolic syndrome. Chest 2005; 127: 1074-5.
50. Tatsumi K, Kasahara Y, Kurosu K, Tanabe N, Takiguchi Y, Kuriyama T. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest 2005; 127: 716-21.
51. Gangwisch JE, Malaspina D, Boden-Albala B, et al. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep 2005; 28: 1289-1296.
52. Smurra M, Philip P, Taillard J, Guilleminault C, Bioulac B, Gin H. CPAP treatment does not affect glucose insulin metabolism in sleep apneic patients. Sleep Med 2001; 2: 207-213.
53. Czupryniak L, Loba J, Pawlowski M, Nowak D, Bialasiewicz P. Treatment with continuous positive airway pressure may affect blood glucose levels in non-diabetic patients with obstructive sleep apnea syndrome. Sleep 2005; 28: 601-603.
54. Saarelainen S, Lahtela J, Kallonen E. Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin. J Sleep Res 1997; 6: 146-7.
55. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25: 735-41.
56. Julius S, Gudbrandsson T. Early association of sympathetic over activity, hypertension, insulin resistance, and coronary risk. J Cardiovasc Pharmacol 1992; 20: S40-8.
57. Boethel CD. Sleep and the endocrine system: New associations to old diseases. Curr Opin Pulm Med 2002; 8: 502-5.
58. Ip MS, Lam B, Ng MMT, Lam WK, Tsang KWT, Lam KSL. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670-6.
59. Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999; 100: 706-12.
60. Ip MS, Lam KS, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000; 118: 580-6.
61. Harsch IA, Schahin SP, Radespiel-Troger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 169: 156-62.
62. Harsch IA, Schahin SP, Bruckner K, et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnea syndrome and type 2 diabetes. Respiration 2004; 71: 252-9.
63. Yee B, Liu P, Philips C, Grunstein R. Neuroendocrine changes in sleep apnea. Curr Opin Pulm Med 2004; 10: 475-81.
64. Weiss H, Spiegler P. The impact of continuous positive airway pressure on insulin resistance in patients with obstructive sleep apnea. Clin Pulm Med 2004; 11: 196-197.
65. Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005; 165: 447-52.